SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is experiencing a sharp sell-off as investors react to back-to-back adverse court rulings regarding the platform's impact on young users, fueling fears that these cases could set a precedent for thousands of future lawsuits. The community is deeply polarized, with some bulls viewing the dip as an overreaction and a buying opportunity, while others are panic-selling, citing concerns over long-term legal liabilities, heavy AI spending, and broader market instability.

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoin is drawing intense investor focus as institutional players like Eightco Holdings pivot toward AI-integrated treasury strategies, fueling community debate over the project's long-term utility in verifying human identity versus concerns regarding its token supply and market volatility. While proponents highlight its potential as an AI-era infrastructure play tied to Sam Altman, others remain skeptical, pointing to recent price weakness and intense selling pressure during broader market shifts.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is facing intense scrutiny and volatility as the market reacts to the President's shifting rhetoric regarding a potential military pause in Iran. Community sentiment is deeply polarized, with critics pointing to portfolio losses and questioning the company's financial fundamentals, while supporters remain vocal about their backing of the administration's aggressive policy maneuvers.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is trending as the community focuses on its strategic partnerships, particularly with Franklin Templeton, to bring tokenized ETFs onto the blockchain. Investors are actively discussing the potential for long-term growth driven by the tokenization of real-world assets, despite concerns regarding token dilution from upcoming unlocks and broader market volatility.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as shares surge on the back of positive Phase 3 clinical trial results for its Zenkuda eye treatment. The community is actively debating the stock's potential for further upside against the risk of future capital raises and the company's past volatility.

Robinhood Ventures Fund I invest in companies located in the United States. The fund focuses on a broad range of sectors and industries. It provides financing for early stage transactions.

Robinhood Ventures Fund I - Common shares of beneficial interest

The community is actively discussing $RVI as a unique, venture-focused investment vehicle, drawing comparisons to $DXYZ and $VCX due to its exposure to high-growth private tech companies. Investors are debating the fund's valuation, speculating on future portfolio additions like SpaceX or OpenAI, and analyzing the impact of its limited share float on potential volatility.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant attention as a speculative proxy for SpaceX and Anthropic exposure, with investors comparing its valuation and portfolio concentration favorably against the recent parabolic run of similar funds like VCX. Community members are actively debating the potential for a major price breakout as they monitor news regarding a possible SpaceX IPO filing, while cautioning that these closed-end funds often face high volatility and premiums to net asset value.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is capturing market attention as institutional investors and the community closely track its progress in the CAR-T autoimmune space, specifically regarding the upcoming BLA submission and Phase 3 registrational trials for miv-cel. Discussion is fueled by strong insider confidence, robust institutional ownership, and anticipation of data readouts from its pipeline targeting conditions like Stiff Person Syndrome and Myasthenia Gravis.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is trending as investors aggressively hedge against market volatility driven by Middle East geopolitical tensions and concerns over potential inflation. Traders are actively debating the sustainability of the current market rally, with many utilizing the inverse fund to hedge their portfolios as they monitor key technical levels and signals of a broader market correction.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is facing intense scrutiny as investors weigh the stock's significant capital expenditure on AI infrastructure against recent operational headwinds, including regional service disruptions and broader supply chain concerns. Despite this pressure, the community remains divided, with active debates centered on whether current price levels offer a long-term entry point for a dominant cloud and logistics leader or if continued macro uncertainty warrants a more cautious, bearish outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Small Caps Push Big Narratives, as Innovation Drives

It’s a relatively quiet session across broader markets, but beneath the surface, a wave of company-specific developments will keep traders engaged. $KBLB, $RAYA, $FEED, $ELAB, $YMT, $PAVS, $UGRO

<ul class="summary-bullets"><li>With the registration, SVM can now legally work on projects involving controlled defense technologies.</li><li>The move aligns with PMGC’s broader strategy of building a portfolio of U.S.-based manufacturing businesses through acquisitions.</li><li>On March 10, the stock traded on a 1-for-6 reverse split basis.&nbsp;</li></ul>PMGC Holdings (ELAB) announced on Tuesday that its subsidiary has achieved a regulatory milestone that could unlock new opportunities in the defense manufacturing sector.&nbsp;The company said its wholly owned unit, SVM Machining, Inc., operating as Silicon Valley Manufacturing, has completed registration under the International Traffic in Arms Regulations&nbsp;(ITAR), a framework overseen by the U.S. State Department.<h2 class="st-heading-2">What ITAR Compliance Means</h2>By securing this registration, SVM can now legally engage in projects involving controlled defense materials and technologies. The designation is often required for companies seeking to participate in U.S. military supply chains or collaborate with aerospace manufacturers on regulated programs.The development positions the company to expand into higher-value contracts tied to U.S. national security and aerospace production.&nbsp;PMGC indicated that the certification strengthens SVM’s prospects of working with top-tier defense contractors and original equipment manufacturers.SVM is a precision machining company serving medical, aerospace, biotech, semiconductor, and transportation sectors.Following the update,&nbsp;<a href="https://stocktwits.com/symbol/ELAB">PMGC stock</a> traded over 46% higher in Tuesday’s premarket.&nbsp;On Stocktwits, retail sentiment around the stock jumped to ‘bullish’ from ‘bearish’ territory the previous day. Message volume shifted to ‘normal’ from ‘low’ levels in 24 hours.&nbsp;<h2 class="st-heading-2">Expansion Into Defense Manufacturing</h2>The move aligns with PMGC’s broader strategy of building a portfolio of U.S.-based manufacturing businesses through acquisitions. In January, PMGC expanded by acquiring non-controlling shares in Nuclea Energy Inc., a company specializing in micro modular reactors and advanced nuclear energy technologies.PMGC completed the acquisition of SVM Machining in February. On March 10, the stock traded on a 1-for-6 reverse split basis.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fubo-stock-set-for-reverse-split-retail-traders-are-not-convinced-raise-questions-on-valuation-after-strong-run/cZ3nhonRIKq">FUBO Stock Set For Reverse Split– Retail Traders Are Not Convinced, Raise Questions On Valuation After Strong Run</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the PMGC Holdings logo is seen displayed on a smartphone screen.

ELAB Stock Soars 46% Pre-Market: Subsidiary Secures Key US Defense Manufacturing Clearance

The company said its subsidiary, SVM Machining, completed ITAR registration, a U.S. State Department-regulated framework governing defense-related technologies.

Why Is ELAB Stock Soaring Today? A Defense Approval Could Be The Trigger

Equity

The company said its subsidiary, SVM Machining, completed ITAR registration, a U.S. State Department-regulated framework governing defense-related technologies.


<ul class="summary-bullets"><li>The filings include five applications for EL-22 and five corresponding applications for EL-32.</li><li>Two applications for the promotion of muscle growth and increase muscle yield per animal, the company said.</li><li>Additional filings target reductions in gaseous emissions and improved animal health.</li></ul>Shares of PMGC Holdings Inc. (ELAB) shot up 12% in pre-market trading on Thursday after the company announced that its unit, NorthStrive Biosciences, filed 10 new U.S. patent applications aimed at expanding its proprietary EL-22 and EL-32 technologies into animal health and agriculture markets.<h2 class="st-heading-2">Patent Expansion Boost For Company</h2>The filings include five applications for EL-22 and five corresponding applications for EL-32, spanning livestock, aquaculture, and poultry sectors. Two applications cover the use of the technologies as non-feed additive supplements to promote muscle growth and increase muscle yield per animal.Additional filings target reductions in gaseous emissions and improved animal health, including mitigation of ruminal tympany, a serious digestive disorder.In aquaculture, the patents address muscle growth, improved production efficiency, and reduced emissions to combat eutrophication, which can lead to low oxygen levels in water bodies. The final set of applications focuses on enhancing muscle development and yield in poultry within standard growth cycles.<h2 class="st-heading-2">Exclusive Licensing Deal With Modulant</h2>This comes just over a week after NorthStrive Biosciences signed an exclusive license with Modulant Biosciences to give the company a worldwide, royalty-bearing license, excluding South Korea, to develop and commercialize products using EL-22 and EL-32 assets. Modulant will handle all development, manufacturing, regulatory, and commercialization activities under the deal.EL-22 helps activate the body’s immune system to block myostatin, a protein that limits muscle growth. When combined with existing GLP-1 weight-loss treatments, this approach could help obese patients lose fat while maintaining healthy muscle mass, the company said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/ELAB">ELAB</a> on Stocktwits flipped to ‘bullish’ from ‘bearish’ a day earlier.<img src="https://news.stocktwits-cdn.com/ELAB_jpg_f7486e001d.webp" alt="ELAB.jpg">One user hoped to see “higher prices soon.”<stembedurl>https://stocktwits.com/NsaneStocks/message/645309441</stembedurl>Another user expects the stock to hit $3 if it breaks past the $1.56 resistance.<stembedurl>https://stocktwits.com/etrade/message/645306771</stembedurl>The stock has been under heavy selling pressure, slumping nearly 77% so far this year.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/cvna-stock-slumps-2026-guidance-concerns-analyst-target-cut/cZRjztsR4Db">CVNA Stock Slumps 10% Pre-Market: Wall Street Questions 2026 Visibility, Retail Flags ‘Deterioration’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

This Heavily Sold Nano-Cap Skincare Stock Jumped 12% Pre-Market – What Happened?

PMGC's unit, NorthStrive Biosciences, filed 10 new U.S. patent applications for EL-22 and EL-32 technologies in the animal health and agriculture markets.

<ul class="summary-bullets"><li>The company stated that Modulant has obtained a worldwide license for the two NorthStrive assets, excluding the Republic of Korea.</li><li>PMGC said that NorthStrive’s EL-22 and EL-32 assets are based on proprietary intellectual property targeting the myostatin and activin-A pathways.</li><li>These pathways are key biological regulators of muscle development, strength, and metabolic efficiency, according to the company.</li></ul>PMGC Holdings Inc. (ELAB) shares soared nearly 45% in Wednesday’s pre-market trade after the company’s wholly-owned subsidiary, NorthStrive Biosciences, signed an exclusive license agreement with Modulant Biosciences.PMGC stated that the license grants Modulant an exclusive, royalty-bearing, sublicensable license to develop, manufacture, and commercialize products using NorthStrive’s EL-22 and EL-32 assets.Retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/ELAB">PMGC Holdings</a> trended in the ‘bullish’ territory at the time of writing, with message volumes at ‘high’ levels.<h2 class="st-heading-2">What Is The Deal About?</h2>PMGC stated that Modulant has obtained a worldwide license for the two NorthStrive assets, excluding the Republic of Korea.The company said that NorthStrive’s EL-22 and EL-32 assets are based on proprietary intellectual property targeting the myostatin and activin-A pathways. These pathways are key biological regulators of muscle development, strength, and metabolic efficiency.PMGC added that these pathways are increasingly being considered as important targets for several applications in animal health and nutrition. This includes productivity of the livestock, feed efficiency, and companion animal muscle health and aging.The company noted that while the license grants Modulant access to EL-22 and EL-32 assets, EL-32 is responsible for all development, manufacturing, regulatory, and commercialization activities.<h2 class="st-heading-2">What Does NorthStrive Do?</h2>NorthStrive is a California-based biopharmaceutical company that is engaged in the development and acquisition of aesthetic medicines.The company stated that its lead asset, EL-22, is designed to preserve muscle during weight-loss treatments, including GLP-1 receptor agonists.<a href="https://stocktwits.com/symbol/ELAB">ELAB stock</a> is down 71% year-to-date and 99% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/qxo-stock-rising-after-agreement-to-acquire-kodiak/cZb6QV0R4qV">QXO Stock Is Soaring Pre-Market Today — What Is Fueling The Surge?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

ELAB Stock Soars Pre-Market As PMGC Subsidiary NorthStrive Signs Exclusive License Agreement With Modulant Biosciences

PMGC stated that the license grants Modulant an exclusive, royalty-bearing, sublicensable license to develop, manufacture, and commercialize products using NorthStrive’s EL-22 and EL-32 assets.

<ul class="summary-bullets"><li>Investors turned cautious ahead of key U.S. jobs data and a potential court ruling on President Donald Trump’s global tariffs expected Friday.&nbsp;</li><li>Retail traders, however, stayed bullish on SPY and QQQ on Stocktwits.</li></ul>U.S. stock futures were lower early Thursday, following a pullback in major indexes. President&nbsp;Donald Trump’s policy comments triggered a late selloff, with defense, financial, and energy stocks under pressure.Investors are also cautious ahead of the big jobs data and the potential US court&nbsp;ruling on Trump’s global tariffs due on Friday.&nbsp;As of 3:00 a.m. ET on Thursday, Nasdaq 100 futures were down 0.3%, S&amp;P 500 futures and Dow futures were down 0.2%, while Russell 2000 futures fell 0.4%.On Stocktwits, however, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, remained ‘bullish’. While sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq 100 Index, has moved back to ‘bullish’ from ‘extremely bullish’ a day ago, amid high message volumes.<h2 class="st-heading-2">Trending Stocks To Watch</h2>Nvidia (NVDA): The Jensen Huang-led chipmaker is reportedly requiring full upfront payment, with&nbsp;no cancellation rights, for H200 chips from Chinese clients to hedge against regulatory export uncertainty. Microsoft (MSFT): The company’s communications&nbsp;chief took to social media to <a href="https://stocktwits.com/news-articles/markets/equity/microsoft-stock-in-focus-as-fresh-layoff-rumors-swirl/cmUGzFNR4PB">blast rumors</a> of fresh mass layoffs as "100% made up," attempting to steady the stock ahead of the&nbsp;market open. Apple (AAPL):&nbsp;Google parent Alphabet (GOOGL) surpassed Apple in market cap for the first time since 2019, closing at $3.888 trillion on Wednesday. It has also switched its banking partner from Goldman Sachs to JPMorgan, the new issuer of the Apple Card.&nbsp; Nio (NIO):&nbsp;The EV maker announced aggressive 2026 expansion plans for Australia, New Zealand, and Thailand, focusing on right-hand-drive markets to bypass Western tariffs. Applied Digital (APLD)&nbsp;saw a high volume of trading following its massive revenue growth report. Ventyx Biosciences (VTYX):&nbsp;Clear Street analyst downgraded the stock to ‘Hold’ from ‘Buy’ with a price target of $14, up from $11, after Eli Lilly (LLY) agreed to acquire Ventyx for $1.2B. Also, LifeSci Capital downgraded it to ‘Market Perform’ from ‘Outperform’ with a $14 price target.&nbsp; Alumis (ALMS) remains on retail radar following a massive ‘follow-on’ financing move following its recent clinical success. Alumis priced an&nbsp;upsized public offering of 17.65 million shares at&nbsp;$17 per share, aiming to raise&nbsp;$300 million. Elevai Labs (ELAB) popped 8%, and&nbsp;Omeros (OMER) rose 5% in after-hours trading on Wednesday, with Omeros gaining steam following a positive FDA conference call on its drug Yartemlea. U.S. defence stocks will be in focus, driven by&nbsp;Trump’s comments to bump up the military budget.Other noteworthy tickers trending on Stocktwits at the time of writing were&nbsp;One Stop Systems (OSS), Paramount Skydance (PSKY), IREN Limited (IREN), Momentus (MNTS), and Regencell Bioscience (RGC).Other Catalysts To Watch On the economic front, investors are looking ahead to the release of Initial Jobless Claims (8:30 a.m. ET), which is a crucial indicator ahead of Friday’s big employment report. Traders will also be monitoring the U.S. Trade Deficit &amp; Productivity data (8:30 a.m. ET) and Consumer Credit data (3 p.m. ET) later today.&nbsp; And noteworthy names on the earnings calendar today include Tilray Brands (TLRY), TD Synnex (SNX),&nbsp;Commercial Metals Company (CMC), and&nbsp;Neogen Corporation (NEOG), among others.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com

Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today

Nvidia, Apple, Microsoft, and select biotech names dominated early market buzz.

Traders work on the floor of the New York Stock Exchange during morning trading on December 10, 2025, in New York City, ahead of the Federal Reserve’s rate decision. 

Why Did ELAB Stock Surge Nearly 8% After-Hours Today?

After a not-so-great 2025, a push to buy a nuclear company has put PMGC Holdings back on investors’ radar.

Shares of PMGC Holdings Inc. jumped 230% in early premarket trading on Tuesday, drawing significant interest from Stocktwits members.Message volume for the ticker on Stocktwits rose a whopping 7,400% in the last 24 hours, and the sentiment reading shifted to 'extremely bullish' as of early Tuesday from 'bullish' the previous day.There was no apparent catalyst for the stock, although several users said they had the ticker on their watchlist.&nbsp;<figure class="image"><img style="aspect-ratio:571/79;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_14_at_1_17_11_PM_png_0063eedc3a.webp" alt="Screenshot 2025-10-14 at 1.17.11 PM.png" width="571" height="79"><figcaption>ELAB sentiment and message volume as of October 14 | Source: Stocktwits</figcaption></figure>PMGC Holdings, which changed its name from Elevai Labs Inc. and also redomiciled from Delaware to Nevada in December 2024, is a U.S.-based holding firm. The company, through its subsidiaries, focuses on cutting-edge aesthetic medicines and therapeutic products for skin aesthetics, obesity, and metabolic health.Its main product, EL-22, is an engineered probiotic designed to help prevent muscle loss during weight loss treatments, such as those using GLP-1 drugs.So far this year, PMGC has approached at least two companies — one manufacturing high-precision parts for the aerospace and defense sectors, and another packing solutions firm — for acquisitions.In August, the company implemented a one-for-3.5 reverse stock split of its common stock.Year-to-date,&nbsp;<a href="https://stocktwits.com/symbol/ELAB">ELAB shares</a> are down 90.7% on a split-adjusted basis. The company had a market cap of $3.5 million as of the stock's last close.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/aka-stock-soars-over-40-after-hours/ch6mi41R3ls">AKA Stock Soars Over 40% After-Hours, Draws Interest From Retail Traders</a>

Traders work on the floor of the New York Stock Exchange during morning trading on September 17, 2025, in New York City. 

PMGC Holdings Stock Jumps 230% Premarket, Grabs Retail Eyeballs

Earlier known as Elevai Labs, PMGC turned into a holding company last year.

Shares of PMGC Holdings Inc. (ELAB) surged over 25% on Monday morning after the company inked a non-binding letter of intent to acquire a U.S. electronics contract manufacturing firm with a four-decade operational track record.This marks PMGC’s second acquisition initiative since April. The agreement pertains to a privately held firm specializing in high-accuracy electronics manufacturing.&nbsp;The target company’s capabilities include assembling electrical and mechanical components, producing printed circuit boards, conducting electronic component evaluations, and offering prototyping services.&nbsp;In 2024, the target company reported approximately $699,000 in revenue and an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of around $173,000.With this latest step, PMGC aims to expand its holdings by acquiring financially sound enterprises recognized for their reliable earnings and growth potential.&nbsp;PMGC executives noted that the acquisition target is distinguished by its efficient operations and long-standing partnerships within the commercial and industrial electronics markets.This acquisition aligns with a broader resurgence in U.S.-based manufacturing, fueled by government initiatives like the CHIPS and Science Act.&nbsp;Enacted on Aug. 9, 2022, the bipartisan CHIPS and Science Act seeks to revitalize the U.S. semiconductor sector while strengthening the country’s research and innovation ecosystem.&nbsp;The legislation allocates $52.7 billion in federal support to initiatives such as building new chip fabrication plants, advancing research and development efforts, and enhancing workforce training.&nbsp;As more supply chains shift back to domestic production, demand for American electronics manufacturers is on the rise.PMGC views this transaction as a timely opportunity to tap into that growing momentum.On Stocktwits, retail sentiment around PMGC changed to ‘extremely bullish’ from ‘bearish’ the previous day.<figure class="image"><img style="aspect-ratio:958/104;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_09_102350_png_3369427ecd.webp" alt="PMGC's Sentiment Meter and Message Volume as of 10:40 a.m. ET on Jun. 9, 2025 | Source: Stocktwits" width="958" height="104"><figcaption>PMGC's Sentiment Meter and Message Volume as of 10:40 a.m. ET on Jun. 9, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed optimism on the shares.<stembedurl>https://stocktwits.com/cjstocksup/message/617252666</stembedurl> <a href="https://stocktwits.com/symbol/ELAB">PMGC</a> stock has lost over 82% in 2025 and over 99% in the last 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/leddar-tech-extends-credit-and-loan-terms-welcomes-back-employees/chlEWXwRby9">LeddarTech Stock Jumps As Company Announces Amended Loan Terms: Retail Stays On The Sidelines</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

PMGC Stock Rockets After Acquiring US Electronics Firm: Retail Ramps Up Exposure

PMGC views the transaction as a timely opportunity, as demand for American electronics manufacturers is on the rise, with more supply chains shifting back to domestic production.

Shares of PMGC Holdings Inc. (Elab) surged more than 50% on Friday as the skin care and biopharma products company said its subsidiary plans to present a probiotic-based weight loss treatment, sparking retail chatter.PMGC, formerly Elevai Labs, said its subsidiary Northstrive Biosciences was invited to present at an upcoming symposium called Anti-Obesity Treatments: Challenges and Emerging Solutions organized by UCLA Metabolism Theme, the company said.This symposium is targeted at obesity-focused clinicians, researchers, drug developers and investors to address the challenges brought up by weight loss treatments.Northstrive Biosciences’ EL-22 product is a probiotic approach for preserving muscle while on weight loss treatments, said the company. Northstrive’s EL-22 is being developed as a potential combination therapy with GLP-1 receptor agonists for preserving muscle while on weight loss treatments. According to studies, about 30-50% of body weight lost with GLP-1 based therapy is lean muscle mass, a common side effect.<stembedurl>https://stocktwits.com/DumbMoneyDoji/message/601529726</stembedurl><stembedurl>https://stocktwits.com/Schizoo/message/601513712</stembedurl>“The rise of anti-obesity medications has put the spotlight on the challenges being faced, particularly the management of muscle and bone loss associated with GLP-1 receptor agonists,” Orian Shirihai, Director of UCLA’s Metabolism Theme, said. “We organized this event to gather obesity’s leading opinion leaders to review the gaps and highlight the emerging solutions.”Last month, PMGC underwent a ‘strategic reorganization’ that included a name change to PMGC Holdings and redomiciling from Delaware to Nevada, in an effort to ‘streamline operations and create a more efficient legal and governance framework.”PMGC specializes in medical aesthetics and biopharmaceuticals with its subsidiaries across skincare, biosciences, research, among others.PMGC stock is up 35% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image. Source: Getty Images

PMGC Stock Surges On Invitation To Present ‘Probiotic’ For Preventing Muscle Loss: Retail Chatter Spikes

Its product, EL-22, is a probiotic approach for preserving muscle while on weight loss treatments

Shares of Elevai Labs Inc. ($ELAB) rose 8% on Friday after the operator of skin care product companies announced a ‘strategic reorganization’ including a name change to PMGC Holdings and redomiciling from Delaware to Nevada, drawing a mixed reaction from retail investors on Stocktwits. After this reorganization, Elevai, which specializes in medical aesthetics and biopharmaceuticals, will continue to trade on The Nasdaq Stock Market under the ticker symbol “ELAB.” The redomestication and name change will go into effect on Nasdaq at the opening of business on December 23, the company said.According to a company statement, the company will focus on enhancing operational efficiencies across its existing entities and pursue ‘synergistic acquisitions’ and also consider ‘strategic divestitures’ of assets that are underperforming or do not align with its long-term strategy. Its decision to redomicile from Delaware to Nevada aligns with its “mission to streamline operations and create a more efficient legal and governance framework,” it added, noting legal benefits such as a business-friendly regulatory environment and potential for long-term cost savings as a result of lower state tax obligations.Retail rection on Stocktwits was a mixed bag.<stembedurl>https://stocktwits.com/CatchingCrumbs/message/597432218</stembedurl><stembedurl>https://stocktwits.com/Chester_Copperpot85/message/597445584</stembedurl>Elavai’s portfolio consists of four wholly owned subsidiaries: Elevai Skincare Inc., Elevai Biosciences Inc., Elevai Research Inc., and PMGC Capital LLC.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Elevai Labs Announces Name Change to PMGC Holdings: Retail’s Cautious

After this reorganization, Elevai will continue to trade on The Nasdaq Stock Market under the ticker symbol “ELAB.”

PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. It is involved in the production and commercialization of topical skincare products that contain its proprietary stem cell-derived Elevai Exosomes. The company was founded by Hatem Abou-Sayed, Braeden William Lichti, and Jordan R. Plews on June 9, 2020 and is headquartered in Newport Beach, CA.

PMGC Holdings Inc

Alphabet $GOOGL

Robinhood $HOOD

Rocket Lab $RKLB

Sandisk $SNDK

The ticker that owned the conversation. This award honors the stock that defined the market narrative through engagement, price action, and cultural presence on the boards.

Current Price	$1.87
Prev Close	$1.82
Open	$1.80
Dividend Yield	0.00%
50-Day Moving Average	$10.17
Beta	1.83
Avg. Volume	513,350.53
PE Ratio	0.00

52-Week High	$466.20
52-Week Low	$1.70
Market Capitalization	$1.01M
EPS (Annual)	-$6,592.46
Price to Book	0.01
Revenue Per Employee	$0.00

ELAB
PMGC Holdings Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ELAB News

ELABPMGC Holdings Inc.